As per reports, Salesforce Inc. (CRM) will launch Vaccine Cloud to assist healthcare providers and the government to globally record, manage, maintain records of COVID-19 vaccinations digitally. The vaccine Cloud will assist people to register and schedule for their vaccine shots, share their vaccination or health status updates helping bring back employees to offices.
“The biggest challenge the world faces right now is orchestrating the distribution of billions of vaccine doses. Technology can play a critical role,” stated Salesforce President and Chief Operating Officer Bret Taylor.
Government agencies and other healthcare organizations need a strong technology infrastructure to handle the huge numbers, speed, and complexity of mass vaccine administration. The new product will allow people to register and schedule for their vaccine shots, in addition to allowing government agencies and public health providers to secure enough vaccine doses and monitor patient outcomes.
Last month, health insurer Cigna Corp, Microsoft Corp, Mayo Clinic, and Salesforce informed that they are a part of an initiative that helps people to store copies of their immunization records in an encrypted digital form in a digital wallet of their choice.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive! Please join us at Vista Partners and receive our FREE email updates throughout the week and view our exclusive content and research.